Literature DB >> 30910822

Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.

Mia Nielsen Christiansen1, Lars Køber1, Christian Torp-Pedersen2, J Gustav Smith3, Finn Gustafsson1, Niels G Vejlstrup1, Peter Damm4, Marianne Johansen4, Charlotte Andersson5, Anne S Ersbøll4.   

Abstract

OBJECTIVES: Peripartum cardiomyopathy (PPCM) is a rare disease carrying a risk of death and chronic heart failure.It is unknown if women with PPCM have a family history of heart failure. We investigated the prevalence of heart failure and hypertension in first-degree relatives to women with PPCM.
METHODS: A cohort of 61 women with PPCM was identified through the nationwide Danish registers from 2005 to 2014, and each individual diagnosis of PPCM was validated through review of patient records. We excluded 13 women due to lack of data on relatives. In a case-control design, the 48 remaining women were matched (on age, year of childbirth, parity and number of siblings) to 477 birth-giving Danish women without heart failure. We obtained information on first-degree relatives (parents and siblings) through the National Danish Registers.
RESULTS: The cohort of 48 women with PPCM had a mean age of 31 years (SD 6). The prevalence of heart failure in any first-degree relative was higher in women with PPCM, compared with controls (23% vs 10%, p=0.011). A first-degree relative with any cardiovascular diagnosis was not more frequent in women with PPCM versus controls (77% vs 70%, p=0.280), but for siblings only, any cardiovascular diagnosis was more frequent in siblings to women with PPCM (29% vs 16%, p=0.026).
CONCLUSION: Having a first-degree relative with heart failure was significantly more frequent in a cohort of validated PPCM cases than in controls, supporting the notion of shared aetiology between PPCM and other forms of heart failure. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; heart failure; pregnancy

Mesh:

Year:  2019        PMID: 30910822     DOI: 10.1136/heartjnl-2018-314552

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  2 in total

Review 1.  Efficacy and safety profile of angiotensin receptor neprilysin inhibitors in the management of heart failure: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Juan Gao; Cong Zhao; Wen-Zhong Zhang; Song Liu; Hui Xin; Zhe-Xun Lian
Journal:  Heart Fail Rev       Date:  2022-10-03       Impact factor: 4.654

2.  Efficacy and safety of sacubitril-valsartan in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials: A PRISMA-compliant article.

Authors:  Jiezhong Lin; Jianyi Zhou; Guiting Xie; Jinguang Liu
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.